Skip to main content
OpenTrials
Completed

NCT Number: NCT01001507

Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya

This is a cluster randomized trial comparing the integration of family planning services into HIV care and treatment programs versus the standard referral for family planning services outside of HIV care and treatment programs within Suba, Kisumu East, Rongo and Migori districts in Nyanza province.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The study will have three parts. During the first part (3 months), baseline data on contraceptive prevalence and unintended pregnancy will be collected at 18 PSCs that are supported by the FACES program in Suba, Kisumu East, Nyatike, Rongo and Migori Districts. Also during this first part, information about knowledge, attitudes and practices related to family planning will be obtained from patients and from clinicians at the sites. During the second part (3 months), an intervention consisting of integrating family planning services will be designed and implemented at twelve of the 18 FACES-supported PSCs. We aim to utilize a 2:1 integration:control model, with delayed integration so as to gradually expand the integration of FP and HIV services throughout the 18 sites, while maintaining the ability to test hypotheses on the effects of integration on health outcomes. After collecting the baseline data, we plan to stratify the clinics into two categories based on the overall patient volume and differences in the structure of family planning provision, i.e., whether or not there is a specific MCH division providing family planning at the site or not. Randomization of sites will then occur among clinics in each of these strata, with a ratio of two intervention sites (integrated model) to one control site (family planning provided in the standard manner at the site). During the third and last part (12 months), data on prevalence more effective contraception and unintended pregnancy will be collected from each of the 18 sites. At the end of part three, information about knowledge, attitudes and practices related to family planning again will be obtained from patients and from clinicians at the sites. In addition, we will administer questionnaires assessing the acceptability of family planning services to patients, and in addition clinic staff will be answer a questionnaire assessing the feasibility of providing integrated family planning services. After 12 months of data collection, the 6 control sites were integrated and data were collected for an additional 11 months from all 18 sites to assess the sustainability of the intervention under the Ministry of Health.

The study population will primarily consist of HIV-positive men and non-pregnant, HIV-positive women of reproductive age who obtain care at the FACES-supported PSCs in Suba, Kisumu East, Rongo and Migori Districts in Nyanza Province, Kenya. In addition, study subjects will also include clinic staff at the FACES centers included in the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For health facilities:

  • Each site must be providing HIV care and treatment services

For participants:

  • Women aged 18-45, not pregnant, HIV+, receiving HIV care at that health facility
  • Men aged 18 and above, HIV+, receiving HIV care at that health facility

Exclusion criteria

For health facilities

  • If they do not meet the inclusion criteria listed above
  • If they are already providing integrated comprehensive HIV care and treatment that includes on-site family planning counseling and provision

For participants:

  • Participants are excluded if they do not meet the inclusion criteria listed above.

Treatment and study plan

Integrated family planning/HIV care and treatment services

Procedure

Family planning services will be provided during the patient's HIV care visit.

Primary outcomes

  1. Prevalence More Effective Contraception (defined as hormonal methods, intrauterine devices, and permanent methods)

    Time frame: 1 year post integration/site initiation and 2 years post integration/site initiation

  2. Pregnancy rate

    Time frame: 1 year post integration/study initiation and 2 years post integration/site initiation

Secondary outcomes

  1. Knowledge of contraceptive methods among HIV-positive women

    Time frame: baseline (months 1-3); post-intervention (months 9-12)

  2. Knowledge of contraceptive methods among providers

    Time frame: baseline (months 1-3); post-intervention (months 9-12)

  3. Acceptability of family planning services

    Time frame: baseline (months 1-3); post-intervention (months 9-12)

  4. Feasibility of providing family planning services at HIV care and treatment centers

    Time frame: months 9-12

  5. Reproductive intentions of HIV-infected women receiving care and treatment

    Time frame: months 1-3

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Bill and Melinda Gates Foundation
  • Ibis Reproductive Health
  • Kenya Medical Research Institute
  • Tides

Registry information

Official study title

Cluster Randomized Trial of Integration of Family Planning Services Into HIV Care and Treatment in Suba, Kisumu East, Rongo and Migori Districts of Nyanza Province

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Oct 26, 2009
Registry last updated
Dec 9, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.